Testosterone Therapy Eases MetS Components in Hypogonadal Men
Researchers observed significant improvements in lipid parameters, blood glucose, and blood pressure.
Researchers observed significant improvements in lipid parameters, blood glucose, and blood pressure.
A new clinical review on cardiovascular disease and testosterone published between 1970 and 2013 has turned up mixed findings.
Review of the literature conducted to assess low testosterone link to cardiovascular disease/mortality.
Desmopressin appears to reduce nocturia and other LUTS while also significantly increasing testosterone levels in late-onset hypogonadism.
Study demonstrates that men experience steady weight loss and decrease in waist circumference.
Findings from a mouse study implicate increased nitric oxide production.
A new study looking at men with low testosterone levels has found that testosterone therapy helps improve pain perception and quality of life.
After radical prostatectomy, men who received testosterone therapy for hypogonadism had a lower rate of biochemical recurrence than nonhypogonadal men.
BMI and waist circumference declined in hypogonadal men treated with parenteral testosterone undecanoate.
Researchers studied 850 testosterone-deficient men who received 1,000 mg parenteral testosterone undecanoate six weeks after baseline and then every 12 weeks for up to five years.